Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and Malignant Melanoma

quinoxalines has been researched along with Malignant Melanoma in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.26)18.7374
1990's0 (0.00)18.2507
2000's3 (15.79)29.6817
2010's14 (73.68)24.3611
2020's1 (5.26)2.80

Authors

AuthorsStudies
Baumann, A; Bonnet, PA; Deleuze-Masquéfa, C; Patinote, C; Pellegrin, E; Raevens, S1
Auzeloux, P; Billoux, T; Cachin, F; Chezal, JM; Degoul, F; Dirat, B; Filaire, M; Jouberton, E; Labarre, P; Maigne, L; Millardet, C; Miot-Noirault, E; Perrot, Y; Valla, C; Vidal, A1
Coelho, P; Prudêncio, C; Silva, L; Soares, R; Vieira, M1
André, M; Chezal, JM; Couret, MJ; Débiton, E; Galmier, MJ; Mounetou, E; Tarrit, S1
Chen, T; Lan, G; Liang, Y; Xie, Q; Yang, L; Zheng, W; Zhou, Y1
Gallagher, SJ; Gowrishankar, K; Gunatilake, D; Hersey, P; Rizos, H; Tiffen, J1
Besse, S; Boudhraa, Z; Cayre, A; Chezal, JM; Degoul, F; Dutreix, M; Herbette, A; Jacquemot, N; Miot-Noirault, E; Mishellany, F; Pereira, B; Ranchon-Cole, I; Sun, JS; Viallard, C1
Bec, N; Bonnet, PA; Cuq, P; Deleuze-Masquéfa, C; Diab-Assaf, M; Guichou, JF; Hadj-Kaddour, K; Kassab, I; Larroque, C; Moarbess, G; Paniagua-Gayraud, S; Vappiani, J; Vincent, LA; Zghaib, Z1
Bradbury, MS; Chen, F; Conrad, M; Gao, M; Gonen, M; Ingold, I; Jiang, X; Kim, SE; Ma, K; Monette, S; Overholtzer, M; Pauliah, M; Quinn, T; Riegman, M; Turker, MZ; Wiesner, U; Zanzonico, P; Zhang, L1
Lee, F; Richmond, A; Smykla, R; Thu, YM; Yang, J; Zaja-Milatovic, S1
Bonnet, PA; Bressolle, F; David, N; Deleuze-Masquefa, C; Gayraud-Paniagua, S; Khier, S; Moarbess, G; Pinguet, F1
Bonnet, PA; Bressolle, FM; Cooper, JF; Deleuze-Masquéfa, C; Gattacceca, F; Khier, S; Margout, D; Moarbess, G; Pinguet, F; Solassol, I1
Barak, V; Chowers, I; Dror, R; Lederman, M; Pe'er, J; Umezawa, K1
Bonnet, M; Cayre, A; Chezal, JM; Madelmont, JC; Miot-Noirault, E; Mishellany, F; Moins, N; Papon, J; Penault-Llorca, F1
Bompart, J; Bonnet, PA; Bressolle, FM; Cooper, JF; Deleuze-Masquéfa, C; El Messaoudi, S; Gattacceca, F; Khier, S; Lafaille, F; Pinguet, F; Solassol, I1
Choo, MK; Cottam, HB; Enzler, T; Karin, M; Park, JM; Sano, Y; Tsao, H1
Berger, A; Eberle, J; Kammermeier, A; Plötz, M; Quast, SA1
Amiri, KI; Burke, JR; Richmond, A; Schmid, JA; Yang, J1
Branda, RF; McCormack, JJ; Perlmutter, CA1

Other Studies

19 other study(ies) available for quinoxalines and Malignant Melanoma

ArticleYear
[1,2,4]triazolo[4,3-
    Molecules (Basel, Switzerland), 2023, Jul-18, Volume: 28, Issue:14

    Topics: Antineoplastic Agents; Cell Line; Humans; Melanoma; Melanoma, Cutaneous Malignant; Molecular Structure; Quinoxalines; Skin Neoplasms; Structure-Activity Relationship

2023
Radiation dosimetry of [
    Medical physics, 2018, Volume: 45, Issue:11

    Topics: Animals; Female; Humans; Iodine Radioisotopes; Male; Melanoma; Quinoxalines; Rabbits; Radiometry; Radiotherapy Dosage; Single Photon Emission Computed Tomography Computed Tomography; Software; Tissue Distribution; Tumor Protein, Translationally-Controlled 1

2018
Quinoxaline-1,4-dioxide derivatives inhibitory action in melanoma and brain tumor cells.
    Future medicinal chemistry, 2019, Volume: 11, Issue:7

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Humans; Melanoma; Mice; Molecular Structure; Quinoxalines; Structure-Activity Relationship

2019
Spacer optimization of new conjugates for a melanoma-selective delivery approach.
    Organic & biomolecular chemistry, 2013, Oct-07, Volume: 11, Issue:37

    Topics: Acetals; Antineoplastic Agents; Cells, Cultured; Drug Delivery Systems; Drug Stability; Humans; Idoxuridine; Melanoma; Molecular Structure; Quinoxalines

2013
Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways.
    Biochemical and biophysical research communications, 2014, Jun-20, Volume: 449, Issue:1

    Topics: Apoptosis; Azoles; Cell Survival; DNA Damage; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; MAP Kinase Signaling System; Melanoma; Oncogene Protein v-akt; Organoselenium Compounds; Quinoxalines; Radiation Tolerance; Radiation-Sensitizing Agents; Reactive Oxygen Species; Signal Transduction; Skin Neoplasms; Treatment Outcome

2014
Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-κB.
    PloS one, 2015, Volume: 10, Issue:4

    Topics: B7-H1 Antigen; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Indoles; Interferon-gamma; Melanoma; NF-kappa B; Quinoxalines; Sulfonamides; Time Factors; Vemurafenib

2015
Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapy.
    Oncotarget, 2016, Mar-15, Volume: 7, Issue:11

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; DNA; DNA Repair; Drug Synergism; Female; Humans; Iodine Radioisotopes; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Quinoxalines; Tumor Protein, Translationally-Controlled 1; Xenograft Model Antitumor Assays

2016
New imidazoquinoxaline derivatives: Synthesis, biological evaluation on melanoma, effect on tubulin polymerization and structure-activity relationships.
    Bioorganic & medicinal chemistry, 2016, 06-01, Volume: 24, Issue:11

    Topics: Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Imidazoles; Melanoma; Molecular Docking Simulation; Molecular Structure; Polymerization; Quinoxalines; Structure-Activity Relationship; Tubulin; Tumor Cells, Cultured

2016
Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth.
    Nature nanotechnology, 2016, Volume: 11, Issue:11

    Topics: alpha-MSH; Amino Acids; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Humans; Iron; Lysosomes; Melanoma; Mice; Mice, SCID; Nanoparticles; Particle Size; Polyethylene Glycols; Quinoxalines; Silicon Dioxide; Spiro Compounds; Xenograft Model Antitumor Assays

2016
Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy.
    Molecular cancer therapeutics, 2009, Volume: 8, Issue:3

    Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Biomarkers, Tumor; Dacarbazine; Drug Delivery Systems; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Niacinamide; Phenylurea Compounds; Pyridines; Quinoxalines; Skin Neoplasms; Sorafenib; Substrate Specificity; Temozolomide; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2009
New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:9

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Imidazoles; Melanoma; Quinoxalines; Structure-Activity Relationship

2009
Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2010, Jan-31, Volume: 39, Issue:1-3

    Topics: Aminoquinolines; Animals; Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Imidazoles; Imiquimod; Injections, Intraperitoneal; Injections, Intravenous; Male; Melanoma; Mice; Mice, Nude; Nitrosourea Compounds; Organophosphorus Compounds; Quinoxalines; Rats; Skin Neoplasms; Xenograft Model Antitumor Assays

2010
Characterizing the involvement of the nuclear factor-kappa B (NF kappa B) transcription factor in uveal melanoma.
    Investigative ophthalmology & visual science, 2010, Volume: 51, Issue:4

    Topics: Apoptosis; Benzamides; Blotting, Western; Caspase 3; Cell Proliferation; Cyclohexanones; Fluorescent Antibody Technique, Indirect; Humans; Imidazoles; Ki-67 Antigen; Liver Neoplasms; Melanoma; NF-kappa B; Quinoxalines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Uveal Neoplasms

2010
Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution.
    Pigment cell & melanoma research, 2010, Volume: 23, Issue:5

    Topics: Animals; Cell Line, Tumor; Humans; Iodine Radioisotopes; Male; Melanins; Melanoma; Melanosomes; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Pigmentation; Quinoxalines; Skin Neoplasms; Transplantation, Heterologous; Tumor Protein, Translationally-Controlled 1

2010
Metabolism and pharmacokinetics of EAPB0203 and EAPB0503, two imidazoquinoxaline compounds previously shown to have antitumoral activity on melanoma and T-lymphomas.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:10

    Topics: Animals; Antineoplastic Agents; Biotransformation; Blood Proteins; Dogs; Humans; Lymphoma, T-Cell; Melanoma; Mice; Microsomes, Liver; Molecular Structure; Protein Binding; Quinoxalines; Rats; Rats, Sprague-Dawley; Species Specificity; Spectrometry, Mass, Electrospray Ionization; Tissue Distribution

2010
Cell-selective inhibition of NF-κB signaling improves therapeutic index in a melanoma chemotherapy model.
    Cancer discovery, 2011, Volume: 1, Issue:6

    Topics: Animals; Apoptosis; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Humans; I-kappa B Kinase; Imidazoles; Interleukin-1beta; Melanoma; Mice; Mice, Inbred C57BL; Myeloid Cells; Neutrophils; NF-kappa B; Protein Kinase Inhibitors; Quinoxalines; Signal Transduction; Xenograft Model Antitumor Assays

2011
Sensitization of melanoma cells for TRAIL-induced apoptosis by BMS-345541 correlates with altered phosphorylation and activation of Bax.
    Cell death & disease, 2013, Jan-24, Volume: 4

    Topics: Apoptosis; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Caspases; Cell Line, Tumor; Humans; I-kappa B Kinase; Imidazoles; Melanoma; Mitochondria; NF-kappa B; Oligopeptides; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Quinoxalines; Recombinant Proteins; RNA Interference; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; X-Linked Inhibitor of Apoptosis Protein

2013
BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Feb-01, Volume: 12, Issue:3 Pt 1

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; I-kappa B Kinase; Imidazoles; In Vitro Techniques; Melanoma; Mice; Mitochondria; NF-kappa B; Quinoxalines; Signal Transduction; Structure-Activity Relationship; Time Factors; Tumor Cells, Cultured

2006
Cellular pharmacology of chloroquinoxaline sulfonamide and a related compound in murine B16 melanoma cells.
    Biochemical pharmacology, 1988, Dec-01, Volume: 37, Issue:23

    Topics: Animals; Cell Division; Cell Line; Chromatography, High Pressure Liquid; Deoxyuridine; DNA; Flow Cytometry; Leucovorin; Melanoma; Mice; Quinoxalines; Sulfanilamides; Sulfaquinoxaline; Tetrahydrofolate Dehydrogenase; Thymidine

1988